Table 2.

Tumor Characteristics	Total	Clear and Confined	Other	p
n	26	10	16
Data Based on Pre-Transplant Imaging Studies
Known Tumor	73.1% (19)	60.0% (6)	81.2% (13)	0.36
# of Dominant Tumor Nodules
1	42.1% (8)	16.7% (1)	53.8% (7)	0.18
2	36.8% (7)	50.0% (3)	30.8% (4)	0.62
3+	21.1% (4)	33.3% (2)	15.4% (2)	0.56
Largest Nodule Diameter in cm (mean +/− SD)	2.87 +/− 1.28	2.28 +/− 0.38	2.78 +/− 1.23	0.80
Total Tumor Diameter in cm (mean +/− SD)	3.79 +/− 1.74	3.76 +/− 0.77	3.31 +/− 1.35	0.15
Bilobar in Patients, % of patients w/ Known	29.4% (5)	50% (3)	15.4% (2)	0.26
Treatment in Patients, % of patients w/ Known
TACE	35.3% (6)	16.7% (1)	38.5% (5)	0.60
RFA	5.0% (1)	0.0% (0)	7.7% (1)	1.00
Resection	0.0% (0)	0.0% (0)	0.0% (0)	n/a
None	64.7% (11)	83.3% (5)	53.8% (7)	0.33
Outside Milan, % of patients w/ Known	35.3% (6)	33.3% (2)	30.8% (4)	1.00
Outside UCSF, % of patients w/ Known	23.5% (4)	33.3% (2)	15.4% (2)	0.55
Data Based on Pathology Examination of Explant
# of Dominant Tumor Nodules
1	34.6% (9)	30.0% (3)	37.5% (6)	1.00
2	23.1% (6)	30.0% (3)	18.8% (3)	0.64
3+	42.3% (11)	40.0% (4)	43.8% (7)	1.00
Largest Nodule Diameter in cm (mean +/− SD)	3.02 +/− 1.44	3.04 +/− 0.76	3.57 +/− 1.61	0.34
Cumulative Tumor Nodule Diameter in cm (mean +/− SD)	4.91 +/− 2.96	6.52 +/− 0.15	5.23 +/− 2.87	0.68
Incidental Tumor(Y), %	26.9% (7)	40.0% (4)	18.8% (3)	0.37
Bilobar (Y), %	88.5% (23)	90.0% (9)	87.5% (14)	0.85
Differentiation, %
Poor	3.8% (1)	10.0% (1)	0.0% (0)	0.41
Moderate to Poor	15.4% (4)	10.0% (1)	18.8% (3)	1.00
Moderate	46.2% (12)	50.0% (5)	43.8% (7)	1.00
Moderate to Well	11.5% (3)	10.0% (1)	7.7% (2)	1.00
Well	3.8% (1)	0.0% (0)	6.2% (1)	1.00
Macroscopic Vascular Invasion	0.0% (0)	0.0% (0)	0.0% (0)	n/a
Microscopic Vascular Invasion	88.5% (23)	90.0% (9)	87.5% (14)	0.85
Positive Surgical Margin	0.0%(0)	0.0% (0)	0.0% (0)	n/a
Positive Lymph Nodes	0.0% (0)	0.0% (0)	0.0% (0)	n/a